These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

149 related articles for article (PubMed ID: 29991454)

  • 1. Preparation of novel phospholipid-based sonocomplexes for improved intestinal permeability of rosuvastatin: In vitro characterization, dynamic simulation, Caco-2 cell line permeation and in vivo assessment studies.
    Abd-Elsalam WH; El-Helaly SN; Ahmed MA; Al-Mahallawi AM
    Int J Pharm; 2018 Sep; 548(1):375-384. PubMed ID: 29991454
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The effect of the saturation degree of phospholipid on the formation of a novel self-assembled nano-micellar complex carrier with enhanced intestinal permeability.
    Ahmed MA; Al-Mahallawi AM; El-Helaly SN; Abd-Elsalam WH
    Int J Pharm; 2019 Oct; 569():118567. PubMed ID: 31352051
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Development and Optimization of Self-emulsifying Drug Delivery Systems (SEDDS) for Enhanced Dissolution and Permeability of Rosuvastatin.
    Karasulu HY; Gündoğdu E; Turgay T; Türk UÖ; Apaydın S; Şimşir IY; Yilmaz C; Karasulu E
    Curr Drug Deliv; 2016; 13(3):362-70. PubMed ID: 27230902
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Enhancing Solubility and Bioavailability of Rosuvastatin into Self Nanoemulsifying Drug Delivery System.
    Karasulu HY; Gundogdu E; Turk UO; Turgay T; Apaydin S; Simsir IY; Yilmaz C; Karasulu E
    Curr Drug Deliv; 2018; 15(7):1072-1082. PubMed ID: 29484996
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Development of β-cyclodextrin-based hydrogel microparticles for solubility enhancement of rosuvastatin: an in vitro and in vivo evaluation.
    Sarfraz RM; Ahmad M; Mahmood A; Akram MR; Abrar A
    Drug Des Devel Ther; 2017; 11():3083-3096. PubMed ID: 29123380
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Enhancing biopharmaceutical attributes of phospholipid complex-loaded nanostructured lipidic carriers of mangiferin: Systematic development, characterization and evaluation.
    Khurana RK; Bansal AK; Beg S; Burrow AJ; Katare OP; Singh KK; Singh B
    Int J Pharm; 2017 Feb; 518(1-2):289-306. PubMed ID: 28025072
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Improving permeability and oral absorption of mangiferin by phospholipid complexation.
    Ma H; Chen H; Sun L; Tong L; Zhang T
    Fitoterapia; 2014 Mar; 93():54-61. PubMed ID: 24220727
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Preparation, characterization and pharmacokinetic evaluation of rosuvastatin calcium incorporated cyclodextrin-polyanhydride nanoparticles.
    Al-Heibshy FNS; Başaran E; Arslan R; Öztürk N; Vural İ; Demirel M
    Drug Dev Ind Pharm; 2019 Oct; 45(10):1635-1645. PubMed ID: 31342792
    [No Abstract]   [Full Text] [Related]  

  • 9. Physicochemical characterization and pharmacokinetic evaluation of rosuvastatin calcium incorporated solid lipid nanoparticles.
    Al-Heibshy FNS; Başaran E; Arslan R; Öztürk N; Erol K; Demirel M
    Int J Pharm; 2020 Mar; 578():119106. PubMed ID: 32014599
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Successful oral delivery of fexofenadine hydrochloride by improving permeability via phospholipid complexation.
    Mandeep ; Kaur S; Samal SK; Roy S; Sangamwar AT
    Eur J Pharm Sci; 2020 Apr; 149():105338. PubMed ID: 32283194
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Improved oral bioavailability and therapeutic efficacy of erlotinib through molecular complexation with phospholipid.
    Dora CP; Kushwah V; Katiyar SS; Kumar P; Pillay V; Suresh S; Jain S
    Int J Pharm; 2017 Dec; 534(1-2):1-13. PubMed ID: 28970115
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Hyaluronic Acid Conjugated Metformin-Phospholipid Sonocomplex: A Biphasic Complexation Approach to Correct Hypoxic Tumour Microenvironment.
    Farag MM; Abd El Malak NS; Yehia SA; Ahmed MA
    Int J Nanomedicine; 2021; 16():1005-1019. PubMed ID: 33603365
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Development of rosuvastatin flexible lipid-based nanoparticles: promising nanocarriers for improving intestinal cells cytotoxicity.
    Ahmed TA
    BMC Pharmacol Toxicol; 2020 Feb; 21(1):14. PubMed ID: 32085802
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Chylomicron mimicking nanocolloidal carriers of rosuvastatin calcium for lymphatic drug targeting and management of hyperlipidemia.
    Beg S; Alam MN; Ahmad FJ; Singh B
    Colloids Surf B Biointerfaces; 2019 May; 177():541-549. PubMed ID: 30825846
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Hexagonal Liquid Crystalline Nanodispersions Proven Superiority for Enhanced Oral Delivery of Rosuvastatin: In Vitro Characterization and In Vivo Pharmacokinetic Study.
    Gabr MM; Mortada SM; Sallam MA
    J Pharm Sci; 2017 Oct; 106(10):3103-3112. PubMed ID: 28479357
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Solid dispersion of berberine-phospholipid complex/TPGS 1000/SiO₂: preparation, characterization and in vivo studies.
    Zhang Z; Chen Y; Deng J; Jia X; Zhou J; Lv H
    Int J Pharm; 2014 Apr; 465(1-2):306-16. PubMed ID: 24456672
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Role of a novel pyridostigmine bromide-phospholipid nanocomplex in improving oral bioavailability.
    Tan QY; Hu NN; Liu GD; Yin HF; Zhang L; Wang H; Lu LY; Zhang JQ
    Arch Pharm Res; 2012 Mar; 35(3):499-508. PubMed ID: 22477197
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Oral Bioavailability Improvement of Tailored Rosuvastatin Loaded Niosomal Nanocarriers to Manage Ischemic Heart Disease: Optimization, Ex Vivo and In Vivo Studies.
    Liu Q; Xu J; Liao K; Tang N
    AAPS PharmSciTech; 2021 Jan; 22(2):58. PubMed ID: 33502651
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Self-nanoemulsifying drug-delivery system for improved oral bioavailability of rosuvastatin using natural oil antihyperlipdemic.
    Abo Enin HA
    Drug Dev Ind Pharm; 2015; 41(7):1047-56. PubMed ID: 25404208
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Phospholipid vesicle-bound lysozyme to enhance permeability in human intestinal cells.
    Witoonsaridsilp W; Panyarachun B; Jaturanpinyo M; Sarisuta N
    Pharm Dev Technol; 2013; 18(4):821-7. PubMed ID: 22762545
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.